Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant Clinical Trials in Ann Arbor, Michigan

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors